Preventive effects of CIDR-based protocols on premature ovulation before timed-AI in Ovsynch in cycling beef cows

Ovsynch is a program developed to synchronize ovulation for timed breeding. In this paper, the authors investigate whether controlled internal drug release (CIDR)-based protocols prevent premature ovulation before timed-artificial insemination (AI) when Ovsynch is started a few days before luteolysis in cycling beef cows. Nine beef cows at 16 days after oestrus were treated with (1) Ovsynch, i.e. gonadotropin releasing hormone (GnRH) analogue on day 0, prostaglandin (PG) F(2alpha) analogue on day 7 and GnRH analogue on day 9 with timed-AI on day 10, (n=3); (2) Ovsynch+CIDR (Ovsynch protocol plus a CIDR for 7 days from day 0, n=3), or (3) oestradiol benzoate (OB)+CIDR+GnRH (OB on day 0 in lieu of the first GnRH treatment, followed by the Ovsynch+CIDR protocol, n=3). In the Ovsynch group (1) plasma progesterone concentrations fell below 0.5 ng/mL earlier (day 5) than in both CIDR-treated groups (2) and (3), where this occurred on day 8. Plasma oestradiol-17beta concentrations peaked on day 8 in the Ovsynch group and on day 9 in both CIDR-treated groups. The dominant follicle ovulated on day 10 in the Ovsynch group and on day 11 in both CIDR-treated groups. Thus, both CIDR-based protocols prevented premature ovulation before timed-AI in Ovsynch when the protocol was started a few days before luteolysis. This reflects the fact that progesterone levels remained high until the beef cattle were treated with PGF(2alpha).     

Some Factors Affecting the Rate of Pregnancy after Embryo Transfer Derived from the Brazilian Jumper Horse Breed

This study aimed to evaluate the effects of certain embryo transfer parameters on the pregnancy rate after equine embryo transfer of the Brazilian Jumper Horse breed. The size, embryonic development stage, embryo quality, and synchronization of ovulation between the donor (n = 120) and recipient (n = 420) were evaluated in 396 embryos. Embryo recovery was performed on Day 6-9 after ovulation (Day 0 = day of ovulation). The recipient mares were chosen on the day of embryo recovery, and the transfers were performed that same day. The embryo size (diameter including envelopes; n = 396) ranged from 150 to 3000 μm; 67.1% measured between 400 and 1199 μm. The embryo size (400-1199 μm vs. ≤399 μm); stage of development (n = 396; blastocyst and expanded blastocyst versus compact morula and early blastocyst); quality (n = 396; grade 1 [excellent]), 2 [good], or 3 [poor]); and synchronization of ovulation between the donor and recipient (0, 1, 2, 3, and 4 days versus −1, 5, and 6 days, respectively) all affected pregnancy rate (P < .05). The pregnancy rate did not differ significantly among transfers performed on Days 0, 1, 2, 3, and 4. In conclusion, embryos measuring 400-1199 μm produced higher pregnancy rates in recipients than embryos measuring 150-399 μm, and blastocysts and expanded blastocysts produced pregnancy more efficiently than morulae and early blastocysts. The embryo quality also affected the pregnancy rate. Synchronization of donor and recipient ovulation to Days 0-4 improved the efficiency of embryo transplant.     

外源ACC通过激活乙烯合成及信号转导诱导小豆抗锈性

大量研究表明, 乙烯可激发植物对死体营养型真菌的抗性, 但我们前期研究发现, 乙烯合成前体ACC可提高小豆对活体营养型真菌——锈菌的抗性, 为初步明确其机制, 本研究分析了ACC处理对小豆乙烯合成及信号转导的影响, 结果表明, ACC处理显著提高了乙烯合成基因VaACS1及信号通路关键基因VaEIN2?VaEIN3?VaERF5的表达水平?此外, ACC处理后再接种锈菌, 小豆锈病的发病程度显著降低?对接种锈菌后不同时间VaPR2和VaPR4的表达分析表明, 相比ACC处理后不接种对照, ACC处理后再接种锈菌的处理, 接种后1~5 d这两个基因表达量显著升高; 与水处理不接种锈菌相比, 水处理接种锈菌5~8 d后VaPR2和VaPR4的表达量虽显著上调, 但应答时间较ACC处理滞后, 且总体表达水平低, 表明ACC激活乙烯通路进而诱导防卫反应基因上调表达是其诱导小豆抗锈性的关键?     

新疆棉花品种次生代谢酶活性与诱导抗蚜性的关系

为了明确不同棉花品种次生代谢酶活性与诱导抗蚜性的关系,研究了不同类型棉花品种在棉蚜为害胁迫下,苯丙氨酸解氨酶(PAL)、过氧化物酶(POD)和多酚氧化酶(PPO)活性的变化及其对抗蚜性的影响。结果表明,未受蚜害时不同品种同一酶活性存在显著差异;受蚜害诱导后,抗蚜品种和感蚜品种3种酶活性均有不同程度的上升,抗蚜品种酶活性显著高于感蚜品种,诱导抗蚜性的强弱在不同品种间差异显著。     

葡萄内生细菌的激活及其对霜霉病菌的抑制作用

为了探究化学诱导剂诱导葡萄抗霜霉病的特性与葡萄内生菌激活的关系,筛选出对葡萄霜霉病有较高生防效果的菌株,本研究通过光学显微镜、扫描电子显微镜观察和传统培养法,检测了葡萄茎段的内生菌,并应用4种化学诱导剂对葡萄叶片和茎段进行处理,对被激活的内生菌进行分离和生防效果的测定.结果显示,在光学显微镜和扫描电子显微镜下均可观察到...     

茉莉酸甲酯调控防御酶活性诱导猕猴桃果实抗采后软腐病

以‘金魁’猕猴桃果实为试验材料,研究茉莉酸甲酯(methyl jasmonate,MeJA)调控防御酶活性抗猕猴桃采后软腐病的效应。测定了MeJA对猕猴桃软腐病病斑直径、软腐病菌Botryosphaeria dothidea抑菌作用及超氧化物歧化酶(SOD)、过氧化氢酶(CAT)、过氧化物酶(POD)、抗坏血酸过氧化物酶(APX)和多酚氧化酶(PPO)等防御酶活性的影响。结果表明:在0.001～10 mmol/L浓度范围内,MeJA对猕猴桃软腐病菌B.dothidea的抑制作用随浓度升高而增强;MeJA对猕猴桃果实最佳诱导浓度和熏蒸时间分别为0.1 mmol/L和24 h,其诱导效果分别为26.01%和26.85%;猕猴桃果实经0.1 mmol/L MeJA熏蒸处理24 h后,SOD、POD、CAT、APX和PPO活性提高,其中SOD和POD活性分别较对照增加33.85%和61.61%,差异达显著水平(P<0.05)。以上结果暗示MeJA诱导猕猴桃果实抗采后软腐病可能与其提高防御酶活性有关。     

母猪诱导发情及排卵效果研究

研究不同方法对母猪的诱导发情及排卵效果的影响。采用3种处理方法对母猪进行了诱导发情及排卵研究。结果表明,PMSG HCG组的诱导发情率与情期受胎率均极显著(P﹤0.01)高于三合激素组、显著(P﹤0.05)高于PMSG组,且PMSG组的诱导发情率与情期受胎率均显著(P﹤0.05)高于三合激素组;经PMSG HCG方法诱导发情处理的母猪,其发情高峰发生在注药后48～96h,母猪发情呈现明显的同期化;PMSG HCG方法处理母猪后,可以提高母猪的产仔数及活仔数,且对受胎率无影响;进一步观察母猪排卵及胚胎发育状况表明,PMSG HCG方法对母猪进行诱导发情及排卵并没有影响胚胎的质量,胚胎开始进入子宫的时间发生在母猪配种后60h以前,此时,胚胎处于4细胞期。说明采用促性腺激素对母猪的诱导发情效果要明显好于性腺激素,且采用适宜剂量的PMSG与HCG混合注射来诱导母猪发情及排卵是完全可行的。     

In vivo activity of native GnRHs and their analogues on ovulation in the African catfish, Clarias gariepinus (Burchell)

Four distinct forms of native gonadotropin‐releasing hormone (GnRH) and two newly designed analogues were tested for their in vivo activity to induce ovulation in African catfish. The effects of these peptides on ovulatory parameters were compared with those of carp pituitary and [d ‐Ala⁶, Pro⁹‐NEt]‐mammalian GnRH analogue (mGnRHa), two tested ovulation‐inducing agents in African catfish. Assessment of ovulation was carried out by determining the ovulation ratio and the relative quantity of egg produced. From the results of the experiments, the order of potency of the native GnRH peptides is summarized as chicken GnRH‐II (cGnRH‐II) >salmon GnRH (sGnRH) >mammalian GnRH >chicken GnRH‐I (cGnRH‐I). Chicken GnRH‐II was as potent as mGnRHa while cGnRH‐I was totally ineffective. The new d ‐Orn⁶‐cGnRH‐II and d ‐Orn⁶‐sGnRH with a substitution at position 6 with d ‐isomer residue were as potent as the most extensively used mGnRHa, indicating that the position 6 modification might be more crucial than the substitution at the C‐terminal. On the basis of our results, the potential use and incorporation of cGnRH‐II and sGnRH for the development of more generic spawning induction therapies are suggested.